Document is current

Any future updates will be listed below

Tocilizumab reduces complement C3 and C4 serum levels in rheumatoid arthritis patients

Crossref DOI link: https://doi.org/10.1007/s10067-018-3992-7

Published Online: 2018-01-23

Published Print: 2018-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark